Where does Validose's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Validose's 1 recorded funding rounds.

Premier Alternatives

Validose

Brooklyn, NY · Founded 2017 · Privately Held (backing)

Developer of an intranasal drug delivery platform designed to deliver medication adherence solutions for clinical trials in real-time. Validose is based in Brooklyn, NY and was founded in 2017. It was valued at $6 million at its seed round in Jan 2025, the last priced event on record. It has raised $2 million across 1 recorded round; the latest was a $1.6 million seed round in Dec 2024.

PMV mark · valuation

$6.0M

Oct 2026

Priced at

its seed round

Jan 2025

Total raised

$2.0M

Last round

Seed Round

Dec 2024

Cap table — not yet on record

Validose's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Validose with a free account

·Watch Validose: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Validose

Where does Validose's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Validose's 1 recorded funding rounds.